Telomerase and the maintenance of chromosome ends

Current Opinion in Cell Biology

Volumn 11, Issue 3, 1999, Pages 318-324

  Bryan, Tracy M ^a   Cech, Thomas R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; RNA DIRECTED DNA POLYMERASE; TELOMERASE;

CELL AGING; CELL SURVIVAL; CHROMOSOME STRUCTURE; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; ENZYME SUBUNIT; PRIORITY JOURNAL; REVIEW; TELOMERE;

EUKARYOTA;

EID: 0033152429     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)80043-X     Document Type: Review

References (61)

1. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
2. Nugent CI, Lundblad V: The telomerase reverse transcriptase: Components and regulation. Genes Dev 1998, 12:1073-1085.
3. Roy J, Fulton TB, Blackburn EH: Specific telomerase RNA residues distant from the template are essential for telomerase function. Genes Dev 1998, 12:3286-3300.
4. Autexier C, Greider CW: Mutational analysis of the Tetrahymena telomerase RNA: Identification of residues affecting telomerase activity in vitro. Nucleic Acids Res 1998, 26:787-795.
5. Lingner J, Cech TR: Purification of telomerase from Euplotes aediculatus: Requirement of a primer 3′ overhang. Proc Natl Acad Sci USA 1996, 93:10712-10717.
6. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR: Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997, 276:561-567. This paper describes the first cloning and characterisation of catalytic subunits of telomerase. The gene for a Euplotes aediculatus protein (p123), previously shown biochemically to copurify with telomerase activity, was cloned and sequenced and found to contain reverse transcriptase motifs. The Saccharomyces cerevisiae homologue of this gene was found to encode Est2p, a protein previously implicated in telomerase action by a genetic screen. Mutation of the conserved reverse transcriptase amino acids led to telomere shortening and senescence in yeast, confirming the identity of this protein as a component of telomerase.
7. Lendvay TS, Morris DK, Sah J, Balasubramanian B, Lundblad V: Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes. Genetics 1996, 144:1399-1412.
8. Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J, Harley CB, Cech TR: Telomerase catalytic subunit homologs from fission yeast and human. Science 1997, 277:955-959. See annotation [9•]
9. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q et al.: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997, 90:785-795. These papers [8•,9•] extended the family of telomerase reverse transcriptases (TERTs) to include members from human and fission yeast, demonstrating their conservation in a wide variety of organisms. Both papers also show that expression of the mRNA of human TERT correlates with telomerase activity in human cell lines and tissues, suggesting that a primary regulation of telomerase activity is provided by TERT expression.
10. Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 1997, 6:2011-2019.
11. Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB, Robinson MO: Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev 1997, 11:3109-3115.
12. Bryan TM, Sperger JM, Chapman KB, Cech TR: Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc Natl Acad Sci USA 1998, 95:8479-8484.
13. Collins K, Gandhi L: The reverse transcriptase component of the Tetrahymena telomerase ribonucleoprotein complex. Proc Natl Acad Sci USA 1998, 95:8485-8490.
14. Greenberg RA, Allsopp RC, Chin L, Morin GB, Depinho RA: Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998, 16:1723-1730.
15. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB et al.: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997, 17:498-502. Telomerase activity was reconstituted in vitro by the expression of hTERT and telomerase RNA in rabbit reticulocyte lysates. Mutation of the conserved reverse transcriptase residues abolished this activity, providing direct evidence for the catalytic function of hTERT. Mutation of amino acids in the telomerase-specific motif 'T' also abolished activity, demonstrating that it is functionally important. This study suggests that TERT and the telomerase RNA form the minimal catalytic core of telomerase, although the contribution of other components of the reticulocyte lysate is not ruled out (see annotation [19•]).
16. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998, 18:65-68.
17. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998, 16:1217-1222.
18. Beattie TL, Zhou W, Robinson MO, Harrington L: Reconstitution of human telomerase activity in vitro. Curr Biol 1998, 8:177-180.
19. Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW et al.: functional requirement of p23 and hsp90 in telomerase complexes. Genes Dev 1999, 13:817-826. Although the expression of hTERT and telomerase RNA in vitro are sufficient for telomerase activity, it is shown here that reconstitution is dependent on factors present in the rabbit reticulocyte lysate used in the transcription/translation reaction, specifically the chaperone proteins p23 and hsp90. They were shown to be associated with TERT by the yeast two-hybrid trap and by immunoprecipitation, and they co-immunoprecipitated with telomerase activity from human cells. An inhibitor of hsp90-p23 activity inhibited telomerase activity in cells, demonstrating that these proteins may also play a role in telomerase assembly in vivo.
20. Gandhi L, Collins K: Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates. Genes Dev 1998, 12:721-733.
21. Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Amgen EST Program, Bass MB, Arruda I, Robinson MO: A mammalian telomerase-associated protein. Science 1997, 275:973-977.
22. Nakayama J, Saito M, Nakamura H, Matsuura A, Ishikawa F: TLP1 : A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family. Cell 1997, 88:1-20.
23. Lingner J, Cech TR, Hughes TR, Lundblad V: Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc Natl Acad Sci USA 1997, 94:11190-11195.
24. Horvath MP, Schweiker VL, Bevilacqua JM, Ruggles JA, Schultz SC: Crystal structure of the Oxytricha nova telomere end binding protein complexed with single strand DNA. Cell 1998, 95:963-974.
25. Froelich-Ammon SJ, Dickinson BA, Bevilacqua JM, Schultz SC, Cech TR: Modulation of telomerase activity by telomere DNA-binding proteins in Oxytricha. Genes Dev 1998, 12:1504-1514.
26. Lin J-J, Zakian VA: The Saccharomyces CDC13 protein is a single-strand TG1-3 telomeric DNA-binding protein in vitro that affects telomere behavior in vivo. Proc Natl Acad Sci USA 1996, 93:13760-13765.
27. Nugent CI, Hughes TR, Lue NF, Lundblad V: Cdc13p: A single-strand telomeric DNA binding protein with a dual role in yeast telomere maintenance. Science 1996, 274:249-252.
28. Shore D: Telomere length regulation: Getting the measure of chromosome ends. Biol Chem 1997, 378:591-597.
29. Marcand S, Gilson E, Shore D: A protein-counting mechanism for telomere length regulation in yeast. Science 1997, 275:986-990. This paper provides a mechanism by which the yeast telomere protein Rap1p may exert control over telomere length. Experiments in which a hybrid Rap1p-Gal4 protein was targeted to a Gal4 binding site next to the telomeric repeats of a yeast chromosome showed that the size of the telomeric tract subsequently decreased by an amount proportional to the number of Rap1p molecules targeted. Thus the number of Rap1p molecules provides a feedback mechanism for telomere length control.
30. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, Tempst P, de Lange T: A human telomeric protein. Science 1995, 270:1663-1667.
31. Bianchi A, Smith S, Chong L, Elias P, de Lange T: TRF1 is a dimer and bends telomeric DNA. EMBO J 1997, 16:1785-1794.
32. van Steensel B, de Lange T: Control of telomere length by the human telomeric protein TRF1. Nature 1997, 385:740-743. The human telomere-binding protein TRF1 acts as a telomerase repressor; overexpression of TRF1 in a telomerase-expressing immortal cell line resulted in gradual telomere shortening, whereas overexpression of mutated TRF1 gave telomere elongation.
33. Griffith J, Bianchi A, de Lange T: TRF1 promotes parallel pairing of telomeric tracts in vitro. J Mol Biol 1998, 278:79-88. Electron microscopy reveals that TRF1 is present on short pieces of telomere-like DNA in dimers or multimers and forms filaments of protein on longer DNA strands. Interestingly, these filaments caused some of the DNA strands to aggregate in pairs, suggesting that TRF1 may mediate telomere-telomere interactions.
34. Smith S, Giriat I, Schmitt A, de Lange T: Tankyrase, a poly(ADP ribose) polymerase at human telomeres. Science 1998, 282:1484-1487. Tankyrase, a novel protein that binds to TRF1, was identified through a two-hybrid screen. Tankyrase has a region homologous to PARP, (poly[adenosine diphosphate-ribose] polymerase), and like PARP has ribosylation activity. Evidence is presented that tankyrase ribosylates TRF1, at least in vitro, and thereby prevents it binding to telomeric DNA, providing a model for the regulation of TRF1 inhibition of telomerase.
35. Broccoli D, Smogorzewska A, Chong L, de Lange T: Human telomeres contain two distinct myb-related proteins, TRF1 and TRF2. Nat Genet 1997, 17:231-235.
36. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E: Telomeric localization of TRF2, a novel human telobox protein. Nat Genet 1997, 17:236-239.
37. van Steensel B, Smogorzewska A, de Lange T: TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413. This paper provides a function for the second human telomere-binding protein, TRF2. Expression of deletion mutants of TRF2 led to over 80% of the cells containing one or more end-to-end fused chromosomes, and evidence was presented that the fusions occurred by blunt-end ligation of telomeric DNA. Thus the protective role of telomeres is likely to be mediated by proteins such as TRF2.
38. Cooper JP, Nimmo ER, Allshire RC, Cech TR: Regulation of telomere length and function by a myb-domain protein in fission yeast. Nature 1997, 385:744-747.
39. Nakamura TM, Cooper JP, Cech TR: Two modes of survival of fission yeast without telomerase. Science 1998, 282:493-496. Schizosaccharomyces pombe that lack TERT experience telomere shortening and senescence although, like Saccharomyces cerevisiae, a subpopulation of cells survives and divides indefinitely. This paper shows that these cells survive by one of two mechanisms: lengthening of telomeres by presumably recombinational means, like S. cerevisiae; or by circularising all three of their chromosomes. The DNA-binding protein Taz1p regulates the recombinational mode of telomere lengthening, as well as telomerase-mediated lengthening.
40. - senescence. Cell 1993, 73:347-360.
41. Gravel S, Larrivee M, Labrecque P, Wellinger RJ: Yeast Ku as a regulator of chromosomal DNA end structure. Science 1998, 280:741-744. This paper confirms the hypothesised role for the DNA-repair protein complex Ku in telomere maintenance. In yeast cells lacking Ku, the single-stranded telomeric overhangs normally present in S-phase are present throughout the cell cycle.
42. Polotnianka RM, Li J, Lustig AJ: The yeast Ku heterodimer is essential for protection of the telomere against nucleolytic and recombinational activities. Curr Biol 1998, 8:831-834. Like [41•], this paper demonstrates that the lack of Ku proteins results in a greater abundance of telomeric single-stranded tails. Furthermore, the telomeres of these mutants are more prone to nucleolytic degradation. These results argue for a protective role for Ku at the telomeres.
43. Boulton SJ, Jackson SP: Components of the ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J 1998, 17:1819-1828.
44. Nugent CI, Bosco G, Ross LO, Evans SK, Salinger AP, Moore JK, Haber JE, Lundblad V: Telomere maintenance is dependent on activities required for end repair of double-strand breaks. Curr Biol 1998, 8:657-660.
45. Feng J, Funk WD, Wang S-S, Weinrich SL, Avilion AA, Chiu C-P, Adams RR, Chang E, Allsopp RC, Yu JH et al.: The RNA component of human telomerase. Science 1995, 269:1236-1241.
46. Singer MS, Gottschling DE: TLC1: Template RNA component of saccharomyces cerevisiae telomerase. Science 1994, 266:404-409.
47. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE: Extension of life span by introduction of telomerase into normal human cells. Science 1998, 279:349-352. See annotation [48••].
48. Vaziri H, Benchimol S: Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr Biol 1998, 8:279-282. These two papers [47••,48••] provide a long-awaited demonstration that maintenance of telomeres can overcome senescence in at least some normal human cells. hTERT was ectopically expressed in BJ foreskin fibroblasts and RPE retinal epithelial cells, and all hTERT expressing clones had longer life spans in vitro than control cells. It is premature to conclude that these cells are immortalised but there is no doubt that they have an extended in vitro life span.
49. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu CP: Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999, 21:111-114. See annotation [50•].
50. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW: Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999, 21:115-118. These two papers provide a continuation of the studies above [47••,48••] on hTERT-expressing normal human cells. These cells have now achieved >200 PD in vitro, supporting the hypothesis that telomerase expression can immortalise human cells. The telomerase-expressing cells demonstrate normal cell-cycle checkpoint control, normal karyotypes and do not form tumours, making them valuable tools for the research of immortalisation.
51. Reddel RR: A reassessment of the telomere hypothesis of senescence. Bioessays 1998, 20:977-984.
52. Holt SE, Wright WE, Shay JW: Regulation of telomerase activity in immortal cell lines. Mol Cell Biol 1996, 16:2932-2939.
53. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ: Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998, 396:84-88. This paper demonstrates that telomerase activity and maintenance of telomeres are not sufficient for the immortalisation of all human cell types. Although hTERT expression did achieve an extended life span for foreskin fibroblasts, immortalisation of mammary epithelial cells and foreskin keratinocytes also required the Rb/p16 growth control pathway to be inactivated. Thus, there are cell-type differences in the control of senescence.
54. Wang J, Xie LY, Allan S, Beach D, Hannon GJ: myc activates telomerase. Genes Dev 1998, 12:1769-1774. This paper also demonstrates the extension of life span of normal human cells by hTERT expression. Interestingly, it is also shown that overexpression of the oncogene c-Myc induces expression of hTERT mRNA and telomerase activity in fibroblasts and epithelial cells. This provides a link between oncogenic transformation by c-Myc and telomerase activity; it is possible that the increased Myc activity in most tumours could be responsible for the high frequency of telomerase-expressing tumours.
55. Huschtscha LI, Noble JR, Neumann AA, Moy EL, Barry P, Melki JR, Clark SJ, Reddel RR: loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells. Cancer Res 1998, 58:3508-3512.
56. Belair CD, Yeager TR, Lopez PM, Reznikoff CA: Telomerase activity: A biomarker of cell proliferation, not malignant transformation. Proc Natl Acad Sci USA 1997, 94:13677-13682. Normal human uroepithelial cells were shown to lack telomerase activity, but activity was detected when these cells were cultured in vitro. Telomerase activity was also detected in bladder carcinomas. The authors interpret these results to indicate that telomerase activity is not related to malignant transformation. In addition, they find that uroepithelial cells in culture have telomerase activity and stable telomeres, yet still undergo senescence. This suggests that at least some cell types do not use telomere shortening as a primary signal for senescence.
57. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, Depinho RA, Greider CW: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34. This description of transgenic mice lacking the RNA component of telomerase has generated much uncertainty regarding the role of telomerase in cell growth and tumourigenesis. Telomerase-negative mice showed a progressive loss of telomeric DNA with each generation and an increase in chromosomal end fusions; however, cells from these mice showed no decrease in their ability to either immortalise in culture or form tumours in nude mice. Thus, either telomerase activation is not a prerequisite for continued cell growth or mice are different from humans in this regard.
58. Lee HW, Blasco MA, Gottlieb GJ, Horner JW II, Greider CW, Depinho RA: essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574. The paper above [57••] generated much surprise that mice were able to reproduce for six generations in the absence of telomerase. This paper demonstrates that the progressive telomere shortening with successive generations does eventually affect cell viability, especially in highly proliferative organs such as the haematopoietic system. Spermatogenesis was defective in late-generation telomerase-negative animals, and no generation seven offspring were produced. This indicates that telomerase is indeed essential for the long-term viability of highly-proliferative cells and therefore of organisms.
59. Virta-Pearlman V, Morris DK, Lundblad V: Est1 has the properties of a single-stranded telomere end-binding protein. Genes Dev 1996, 10:3094-3104.
60. Harley CB, Futcher AB, Greider CW: Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
61. Autexier C, Greider CW: Telomerase and cancer: Revisiting the telomere hypothesis. Trends Biochem Sci 1996, 21:387-391